Pfizer's dividend yield is around 7.3%, which is super generous. If you have an opening in your portfolio for a great stock ...

Artificial intelligence trading tools that analyze reams of data and build portfolios are already shaking up Wall Street. But ...

The AI and data cloud Snowflake has announced enhanced warehouse features providing auto-tuning, more power, and more cost ...

With Main Street investors now able to trade as fast as some qualitative hedge funds, seismic changes could be ahead for the ...

In a report released yesterday, Vamil Divan from Guggenheim maintained a Buy rating on Savara (SVRA – Research Report), with a price target of $8.00. The company’s shares clos ...

David Bryant brings over three and a half decades of experience in the pharmaceutical industry, having held commercial leadership positions at GSK (LON:GSK) and Pfizer (NYSE:PFE). He was part of ...

The CDC will no longer recommend the COVID-19 vaccine for pregnant women and healthy children. Updated COVID-19 shots will ...

(Bloomberg) -- Before the lawsuits started piling up in courtrooms across Connecticut, before his employer accused him of running a “massive Ponzi-like fraud,” and before the FBI showed up, Robert ...

As a consequence of Pfizer’s innovation, the price of citric acid tumbled over ... Pfizer seemed unable to allay the concerns of prime minister David Cameron and business secretary Vince Cable.

And with an eye to today’s Apple’s Worldwide Developers Conference, investors are hoping that technology stocks will help ...

In clinical trials, the tyrosine kinase inhibitor demonstrated a confirmed overall response rate of up to 90 percent and brain-penetrant efficacy.

The dividend remains well supported -- the REIT reported funds from operations ( FFO) per share of $1.05 during the first ...